These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 22107694)

  • 1. TLR2 in pleural fluid is modulated by talc particles during pleurodesis.
    Jankovicova K; Kondelkova K; Habal P; Andrys C; Krejsek J; Mandak J
    Clin Dev Immunol; 2012; 2012():158287. PubMed ID: 23304186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system.
    Lendemans S; Kreuzfelder E; Rani M; Bayeeh E; Schade FU; Flohé SB; Waydhas C; Flohé S
    J Trauma; 2007 Oct; 63(4):740-6. PubMed ID: 18089999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects.
    Ramlow W; Emmrich J; Ahrenholz P; Sparmann G; Kashiwagi N; Franz M; Yokoyama T; Yoshikawa T
    J Clin Apher; 2005 Jul; 20(2):72-80. PubMed ID: 15892085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-alpha or interleukin-1beta in human peripheral blood.
    Takeda Y; Hiraishi K; Takeda H; Shiobara N; Shibusawa H; Saniabadi AR; Adachi M; Kawata S
    Inflamm Res; 2003 Jun; 52(7):287-90. PubMed ID: 12861393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialyzable leukocyte extract differentially regulates the production of TNFalpha, IL-6, and IL-8 in bacterial component-activated leukocytes and endothelial cells.
    Ojeda MO; van't Veer C; Fernández Ortega CB; Araña Rosainz Mde J; Buurman WA
    Inflamm Res; 2005 Feb; 54(2):74-81. PubMed ID: 15750714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?
    Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R
    J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes.
    Saniabadi AR; Hanai H; Takeuchi K; Umemura K; Nakashima M; Adachi T; Shima C; Bjarnason I; Lofberg R
    Ther Apher Dial; 2003 Feb; 7(1):48-59. PubMed ID: 12921115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in the apheresis procedure for the treatment of inflammatory bowel disease.
    Pineda AA
    Inflamm Bowel Dis; 2006 Jan; 12 Suppl 1():S10-4. PubMed ID: 16378005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and basic studies on the G-1 column, a new extracorporeal therapeutic device effective in controlling rheumatoid arthritis.
    Kyogoku M; Kasukawa R
    Inflamm Res; 1998 Oct; 47 Suppl 3():S166-76. PubMed ID: 9831320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-modulation of toll-like receptor 2 expression on granulocytes and suppression of interleukin-8 production due to in vitro treatment with cellulose acetate beads.
    Hidaka M; Fukuzawa K
    Ther Apher Dial; 2011 Dec; 15(6):572-8. PubMed ID: 22107694
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.